IL6 and acute coronary syndrome: Longitudinal studies have demonstrated that Interleukin 6 (IL-6) is a better predictor of CHF after acute coronary syndrome (ACS) than C-reactive protein (CRP) [13], and that it is also an independent predictor of cardiovascular mortality [14].